# Caesars Entertainment, Inc.: financial statements, quarterly

CZR · Nasdaq · CIK 1590895 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/czr.md) · [Financials](/companies/czr/financials.md) · [Filings](/companies/czr/filings.md) · [Insiders](/companies/czr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/czr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,825 d](/filings/0001590895-26-000011.md) | [2,742](/filings/0001590895-25-000110.md) | [2,830](/filings/0001590895-25-000126.md) | [2,874](/filings/0001590895-25-000130.md) | [2,799 d](/filings/0001590895-26-000011.md) | [2,794](/filings/0001590895-26-000016.md) | [2,907](/filings/0001590895-26-000028.md) | [2,869](/filings/0001590895-26-000033.md) | [2,916 d](/filings/0001590895-26-000011.md) | [2,870](/filings/0001590895-26-000016.md) | [2,993](/filings/0001590895-26-000028.md) | [2,940](/filings/0001590895-26-000033.md) |
| Operating income | $m | [536 d](/filings/0001590895-26-000011.md) | [485](/filings/0001590895-25-000110.md) | [506](/filings/0001590895-25-000126.md) | [644](/filings/0001590895-25-000130.md) | [669 d](/filings/0001590895-26-000011.md) | [488](/filings/0001590895-26-000016.md) | [526](/filings/0001590895-26-000028.md) | [513](/filings/0001590895-26-000033.md) | [331 d](/filings/0001590895-26-000011.md) | [500](/filings/0001590895-26-000016.md) | [513](/filings/0001590895-26-000028.md) | [457](/filings/0001590895-26-000033.md) |
| Interest expense | $m | [596 d](/filings/0001590895-26-000011.md) | [607](/filings/0001590895-24-000088.md) | [614](/filings/0001590895-25-000126.md) | [616](/filings/0001590895-25-000130.md) | [601 d](/filings/0001590895-26-000011.md) | [582](/filings/0001590895-26-000016.md) | [587](/filings/0001590895-26-000028.md) | [582](/filings/0001590895-26-000033.md) | [578 d](/filings/0001590895-26-000011.md) | [572](/filings/0001590895-26-000016.md) | [577](/filings/0001590895-26-000028.md) | [573](/filings/0001590895-26-000033.md) |
| Income tax | $m | [16.0 d](/filings/0001590895-26-000011.md) | [15.0](/filings/0001590895-25-000110.md) | [10.0](/filings/0001590895-25-000126.md) | [43.0](/filings/0001590895-25-000130.md) | [19.0 d](/filings/0001590895-26-000011.md) | [11.0](/filings/0001590895-26-000016.md) | [13.0](/filings/0001590895-26-000028.md) | [(25.0)](/filings/0001590895-26-000033.md) | [(10.0) d](/filings/0001590895-26-000011.md) | [12.0](/filings/0001590895-26-000016.md) | [(12.0)](/filings/0001590895-26-000028.md) | [(10.0)](/filings/0001590895-26-000033.md) |
| Net income | $m | [(72.0) d](/filings/0001590895-26-000011.md) | [(158)](/filings/0001590895-25-000110.md) | [(122)](/filings/0001590895-25-000126.md) | [(9.0)](/filings/0001590895-25-000130.md) | [11.0 d](/filings/0001590895-26-000011.md) | [(115)](/filings/0001590895-26-000016.md) | [(82.0)](/filings/0001590895-26-000028.md) | [(55.0)](/filings/0001590895-26-000033.md) | [(250) d](/filings/0001590895-26-000011.md) | [(98.0)](/filings/0001590895-26-000016.md) | [(62.0)](/filings/0001590895-26-000028.md) | [(123)](/filings/0001590895-26-000033.md) |
| Diluted EPS | $ per share | not reported | [(0.73)](/filings/0001590895-25-000110.md) | [(0.56)](/filings/0001590895-25-000126.md) | [(0.04)](/filings/0001590895-25-000130.md) | not reported | [(0.54)](/filings/0001590895-26-000016.md) | [(0.39)](/filings/0001590895-26-000028.md) | [(0.27)](/filings/0001590895-26-000033.md) | not reported | [(0.48)](/filings/0001590895-26-000016.md) | [(0.30)](/filings/0001590895-26-000028.md) | [(0.61)](/filings/0001590895-26-000033.md) |
| Basic EPS | $ per share | not reported | [(0.73)](/filings/0001590895-25-000110.md) | [(0.56)](/filings/0001590895-25-000126.md) | [(0.04)](/filings/0001590895-25-000130.md) | not reported | [(0.54)](/filings/0001590895-26-000016.md) | [(0.39)](/filings/0001590895-26-000028.md) | [(0.27)](/filings/0001590895-26-000033.md) | not reported | [(0.48)](/filings/0001590895-26-000016.md) | [(0.30)](/filings/0001590895-26-000028.md) | [(0.61)](/filings/0001590895-26-000033.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0001590895-26-000011.md) | [0.7](/filings/0001590895-25-000110.md) | [0.8](/filings/0001590895-25-000126.md) | [0.8](/filings/0001590895-25-000130.md) | [0.9](/filings/0001590895-26-000011.md) | [0.9](/filings/0001590895-26-000016.md) | [1.0](/filings/0001590895-26-000028.md) | [0.8](/filings/0001590895-26-000033.md) | [0.9](/filings/0001590895-26-000033.md) | [0.9](/filings/0001590895-26-000016.md) | [1.0](/filings/0001590895-26-000028.md) | [0.9](/filings/0001590895-26-000033.md) |
| Current assets | $bn | [2.0](/filings/0001590895-25-000068.md) | [1.7](/filings/0001590895-24-000088.md) | [1.8](/filings/0001590895-24-000124.md) | [1.9](/filings/0001590895-24-000138.md) | [1.7](/filings/0001590895-26-000011.md) | [1.8](/filings/0001590895-25-000110.md) | [1.9](/filings/0001590895-25-000126.md) | [1.7](/filings/0001590895-25-000130.md) | [1.8](/filings/0001590895-26-000033.md) | [1.8](/filings/0001590895-26-000016.md) | [2.0](/filings/0001590895-26-000028.md) | [1.8](/filings/0001590895-26-000033.md) |
| Total assets | $bn | [33.4](/filings/0001590895-25-000068.md) | [33.1](/filings/0001590895-24-000088.md) | [33.1](/filings/0001590895-24-000124.md) | [33.0](/filings/0001590895-24-000138.md) | [32.6](/filings/0001590895-26-000011.md) | [32.4](/filings/0001590895-25-000110.md) | [32.5](/filings/0001590895-25-000126.md) | [31.9](/filings/0001590895-25-000130.md) | [31.6](/filings/0001590895-26-000033.md) | [31.7](/filings/0001590895-26-000016.md) | [31.7](/filings/0001590895-26-000028.md) | [31.4](/filings/0001590895-26-000033.md) |
| Current liabilities | $bn | [2.7](/filings/0001590895-25-000068.md) | [2.5](/filings/0001590895-24-000088.md) | [2.6](/filings/0001590895-24-000124.md) | [2.3](/filings/0001590895-24-000138.md) | [2.3](/filings/0001590895-26-000011.md) | [2.1](/filings/0001590895-25-000110.md) | [2.3](/filings/0001590895-25-000126.md) | [2.2](/filings/0001590895-25-000130.md) | [2.3](/filings/0001590895-26-000033.md) | [2.1](/filings/0001590895-26-000016.md) | [2.3](/filings/0001590895-26-000028.md) | [2.2](/filings/0001590895-26-000033.md) |
| Total liabilities | $bn | [28.6](/filings/0001590895-25-000068.md) | [28.5](/filings/0001590895-24-000088.md) | [28.6](/filings/0001590895-24-000124.md) | [28.6](/filings/0001590895-24-000138.md) | [28.2](/filings/0001590895-26-000011.md) | [28.1](/filings/0001590895-25-000110.md) | [28.4](/filings/0001590895-25-000126.md) | [27.9](/filings/0001590895-25-000130.md) | [28.0](/filings/0001590895-26-000033.md) | [28.1](/filings/0001590895-26-000016.md) | [28.2](/filings/0001590895-26-000028.md) | [27.9](/filings/0001590895-26-000033.md) |
| Long-term debt | $bn | [12.2](/filings/0001590895-25-000068.md) | [12.2](/filings/0001590895-24-000088.md) | [12.2](/filings/0001590895-24-000124.md) | [12.4](/filings/0001590895-24-000138.md) | [12.0](/filings/0001590895-26-000011.md) | [12.0](/filings/0001590895-25-000110.md) | [12.0](/filings/0001590895-25-000126.md) | [11.7](/filings/0001590895-25-000130.md) | [11.7](/filings/0001590895-26-000033.md) | [11.7](/filings/0001590895-26-000016.md) | [11.6](/filings/0001590895-26-000028.md) | [11.4](/filings/0001590895-26-000033.md) |
| Current portion of debt | $bn | [0.1](/filings/0001590895-25-000068.md) | [0.1](/filings/0001590895-24-000088.md) | [0.1](/filings/0001590895-24-000124.md) | [0.1](/filings/0001590895-24-000138.md) | [0.1](/filings/0001590895-26-000011.md) | [0.1](/filings/0001590895-25-000110.md) | [0.1](/filings/0001590895-25-000126.md) | [0.1](/filings/0001590895-25-000130.md) | [0.1](/filings/0001590895-26-000033.md) | [0.1](/filings/0001590895-26-000016.md) | [0.1](/filings/0001590895-26-000028.md) | [0.1](/filings/0001590895-26-000033.md) |
| Shareholders' equity | $bn | [4.6](/filings/0001590895-25-000068.md) | [4.4](/filings/0001590895-24-000088.md) | [4.3](/filings/0001590895-24-000124.md) | [4.2](/filings/0001590895-24-000138.md) | [4.2](/filings/0001590895-26-000011.md) | [4.1](/filings/0001590895-25-000110.md) | [3.9](/filings/0001590895-25-000126.md) | [3.8](/filings/0001590895-25-000130.md) | [3.5](/filings/0001590895-26-000033.md) | [3.4](/filings/0001590895-26-000016.md) | [3.4](/filings/0001590895-26-000028.md) | [3.3](/filings/0001590895-26-000033.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [508 d](/filings/0001590895-26-000011.md) | [80.0](/filings/0001590895-25-000110.md) | [454 d](/filings/0001590895-25-000126.md) | [232 d](/filings/0001590895-25-000130.md) | [309 d](/filings/0001590895-26-000011.md) | [218](/filings/0001590895-26-000016.md) | [462 d](/filings/0001590895-26-000028.md) | [318 d](/filings/0001590895-26-000033.md) | [304 d](/filings/0001590895-26-000011.md) | [204](/filings/0001590895-26-000016.md) | [471 d](/filings/0001590895-26-000028.md) | [267 d](/filings/0001590895-26-000033.md) |
| Capital expenditure | $m | [369 d](/filings/0001590895-26-000011.md) | [264](/filings/0001590895-25-000110.md) | [329 d](/filings/0001590895-25-000126.md) | [424 d](/filings/0001590895-25-000130.md) | [279 d](/filings/0001590895-26-000011.md) | [223](/filings/0001590895-26-000016.md) | [230 d](/filings/0001590895-26-000028.md) | [195 d](/filings/0001590895-26-000033.md) | [157 d](/filings/0001590895-26-000011.md) | [168](/filings/0001590895-26-000016.md) | [167 d](/filings/0001590895-26-000028.md) | [172 d](/filings/0001590895-26-000033.md) |
| Share repurchases | $m | [0.0 d](/filings/0001590895-26-000011.md) | not reported | not reported | [141 d](/filings/0001590895-25-000130.md) | [50.0 d](/filings/0001590895-26-000011.md) | not reported | not reported | [79.0 d](/filings/0001590895-26-000033.md) | [50.0 d](/filings/0001590895-26-000011.md) | not reported | not reported | [0.0 d](/filings/0001590895-26-000033.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [215](/filings/0001590895-24-000088.md) | [216](/filings/0001590895-24-000124.md) | [216](/filings/0001590895-24-000138.md) | [216](/filings/0001590895-25-000110.md) | [216](/filings/0001590895-25-000126.md) | [215](/filings/0001590895-25-000130.md) | [212](/filings/0001590895-26-000016.md) | [209](/filings/0001590895-26-000028.md) | [207](/filings/0001590895-26-000033.md) | [204](/filings/0001590895-26-000016.md) | [204](/filings/0001590895-26-000028.md) | [204](/filings/0001590895-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 203,807,108 at 2026-10-22, from the cover of the [10-Q filed 2026-10-27](/filings/0001590895-26-000033.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 18:21 ET. No prices; not investment advice.